Recently President Trump signed the Consolidated Appropriations Act, 2021—a funding measure which extends certain emergency authorities and temporary regulatory relief contained in the CARES Act (covered by InfoBytes here)—that includes a provision under Title XIV Covid-19 Consumer Protection Act, which allows the FTC to seek civil penalties for first-time violations of the FTC Act related to Covid-19 scams and deceptive practices. Specifically, the provision targets conduct “associated with—(1) the treatment, cure, prevention, mitigation, or diagnosis of COVID-19; or (2) a government benefit related to COVID-19.” Such a violation would be “treated as a violation of a rule defining an unfair or deceptive act or practice prescribed under section 18(a)(1)(B) of the Federal Trade Commission Act (15 U.S.C. 57a(a)(1)(B)),” with violators subject to civil penalties. This authority is granted to the FTC for the duration of the Covid-19 pandemic.